Cancer drug development: Problems and opportunities

被引：0
|
作者：
Markman, M
机构：
[1] Cleveland Clin Fdn, Dept Hematol Med Oncol, Cleveland, OH 44195 USA
[2] Cleveland Clin, Ctr Canc, Cleveland, OH 44106 USA
来源：
DRUG INFORMATION JOURNAL | 1998年 / 32卷 / 01期
关键词：
cancer; oncologic drug development; pharmaceutical industry;
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
The pharmaceutical industry must direct additional focus on the development of agents to prevent or minimize symptoms of cancer and its treatment, and maximize the qualify of life of cancer patients. This paper covers the current status of cancer chemotherapy, opportunties for intervention supportive care measures, and challenges to the pharmaceutical industry in oncologic drug development.
引用
收藏
页码：1 / 5
页数：5
相关论文
共 50 条
  • [1] Cancer Drug Development Problems and Opportunities
    Maurie Markman
    Drug information journal : DIJ / Drug Information Association, 1998, 32 (1): : 1 - 5
  • [2] Challenges and Opportunities for Childhood Cancer Drug Development
    Houghton, Peter J.
    Kurmasheva, Raushan T.
    PHARMACOLOGICAL REVIEWS, 2019, 71 (04) : 671 - 697
  • [3] Challenges and opportunities in childhood cancer drug development
    Robin E. Norris
    Peter C. Adamson
    Nature Reviews Cancer, 2012, 12 : 776 - 782
  • [4] Challenges and opportunities in childhood cancer drug development
    Norris, Robin E.
    Adamson, Peter C.
    NATURE REVIEWS CANCER, 2012, 12 (11) : 776 - 782
  • [5] Opportunities and Challenges in the Development of Experimental Drug Combinations for Cancer
    Humphrey, Rachel W.
    Brockway-Lunardi, Laura M.
    Bonk, David T.
    Dohoney, Kathleen M.
    Doroshow, James H.
    Meech, Sandra J.
    Ratain, Mark J.
    Topalian, Suzanne L.
    Pardoll, Drew M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (16): : 1222 - 1226
  • [6] Drug Development and Registration: Challenges and Opportunities in Ovarian Cancer
    Ivy, S. Percy
    Kohn, Elise C.
    CANCER, 2017, 123 (14) : 2597 - 2599
  • [7] Emerging Targets in Kidney Cancer: Opportunities for Drug Development
    Stadler, Walter
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 299 - 300
  • [8] Drug development in advanced colorectal cancer: Challenges and opportunities
    Robin K. Kelley
    Alan P. Venook
    Current Oncology Reports, 2009, 11 : 175 - 185
  • [9] Opportunities and challenges of implementing Pharmacogenomics in cancer drug development
    Tarantino, Paolo
    Trapani, Dario
    Morganti, Stefania
    Ferraro, Emanuela
    Viale, Giulia
    D'Amico, Paolo
    Duso, Bruno Achutti
    Curigliano, Giuseppe
    CANCER DRUG RESISTANCE, 2019, 2 (01) : 43 - 52
  • [10] Drug Development in Advanced Colorectal Cancer: Challenges and Opportunities
    Kelley, Robin K.
    Venook, Alan P.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (03) : 175 - 185
12345